Skip to main content
. 2026 May 8;105(19):e48574. doi: 10.1097/MD.0000000000048574

Table 1.

Baseline characteristics at index time.

Characteristic Supportive (n = 210) Augmentation (n = 164) Manual rotation (n = 148) rOVD (n = 90) P value
Maternal age, yr 31.1 (4.4) 31.0 (4.9) 30.6 (4.4) 31.3 (3.8) .597
BMI, kg/m2 26.5 (3.9) 26.5 (4.2) 26.5 (3.4) 26.4 (3.7) .992
Gestational age, wk 39.0 (1.0) 39.2 (1.0) 38.9 (1.0) 39.0 (1.0) .262
Cervical dilation at index, cm 6.3 (0.8) 6.2 (0.8) 6.2 (0.8) 7.0 (0.7) <.001
Age ≥ 35 yr 43/210 (20.5%) 39/164 (23.8%) 26/148 (17.6%) 15/90 (16.7%) .448
BMI ≥ 30 kg/m2 41/203 (20.2%) 34/159 (21.4%) 23/145 (15.9%) 14/87 (16.1%) .535
Gestational age ≥ 41 wk 8/210 (3.8%) 6/164 (3.7%) 5/148 (3.4%) 3/90 (3.3%) .995
Nulliparous 153/210 (72.9%) 122/164 (74.4%) 112/148 (75.7%) 61/90 (67.8%) .584
Induction of labor 59/210 (28.1%) 39/164 (23.8%) 43/148 (29.1%) 24/90 (26.7%) .726
Epidural analgesia 130/209 (62.2%) 94/161 (58.4%) 90/147 (61.2%) 55/90 (61.1%) .901
Ruptured membranes at index 127/210 (60.5%) 85/164 (51.8%) 86/148 (58.1%) 61/90 (67.8%) .088
Oxytocin exposure prior to index 64/210 (30.5%) 36/164 (22.0%) 34/148 (23.0%) 17/90 (18.9%) .098
Meconium-stained fluid 18/210 (8.6%) 22/164 (13.4%) 26/148 (17.6%) 12/90 (13.3%) .091
Suspected CPD 17/210 (8.1%) 15/164 (9.1%) 18/148 (12.2%) 13/90 (14.4%) .312
FHR abnormality at index 28/210 (13.3%) 24/164 (14.6%) 23/148 (15.5%) 14/90 (15.6%) .932
Fetal station distribution at index time (P = .572)
Station at index Supportive Augmentation Manual rotation rOVD
−2 21 (10.0%) 19 (11.6%) 18 (12.2%) 9 (10.0%)
−1 62 (29.5%) 57 (34.8%) 44 (29.7%) 25 (27.8%)
0 72 (34.3%) 48 (29.3%) 45 (30.4%) 22 (24.4%)
+1 39 (18.6%) 22 (13.4%) 27 (18.2%) 21 (23.3%)
+2 16 (7.6%) 18 (11.0%) 14 (9.5%) 13 (14.4%)

BMI = body mass index, CPD = cephalopelvic disproportion, FHR = fetal heart rate, rOVD = rotational operative vaginal delivery.